MRK
22
3
DNB
78
6
AKAM
43
3
A
36
2
RSG
68
3
HAS
30
2
CVX
46
5
JNPR
46
3
APA
21
2
HSIC
54
-3
UPS
41
-4
IP
70
2
TDC
75
4
RRC
63
3
BA
52
2
MRO
55
3
XOM
47
5
ILMN
32
-3
DVA
72
2
JNJ
41
2
MRK
22
3
DNB
78
6
AKAM
43
3
A
36
2
RSG
68
3
HAS
30
2
CVX
46
5
JNPR
46
3
APA
21
2
HSIC
54
-3
UPS
41
-4
IP
70
2
TDC
75
4
RRC
63
3
BA
52
2
MRO
55
3
XOM
47
5
ILMN
32
-3
DVA
72
2
JNJ
41
2
Financhill
Back

Genmab AS Vs. Novo Nordisk AS Industry Stock Comparison

Sell
25

GMAB
Genmab AS

Last Price:
20.48
Seasonality Move:
3.28%
Sell
39

NVO
Novo Nordisk AS

Last Price:
102.64
Seasonality Move:
10.2%
Sell
25
Genmab AS (GMAB) is a Sell

Is Genmab AS a Buy, Sell or Hold?

  • The current Genmab AS [GMAB] share price is $20.45. The Score for GMAB is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • GMAB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NVO] share price is $105.27. The Score for NVO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GMAB Stock Price Chart

What is Genmab AS's stock price today?

  • The Genmab AS share price today is $20.45
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GMAB is experiencing slight selling pressure.

NVO Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $105.27
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing buying pressure, which is a positive indicator for future bullish movement.

GMAB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.79 Sell
Relative Strength Index (14 RSI): 25.28 Sell
Chaikin Money Flow: -57518 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (21.45 - 23.25) Sell
Bollinger Bands (100): (23.03 - 27.51) Sell

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.99 Sell
Relative Strength Index (14 RSI): 39.43 Sell
Chaikin Money Flow: 4658888 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (105.04 - 115.16) Sell
Bollinger Bands (100): (114.07 - 136.97) Sell

GMAB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.34 Sell
20-day SMA: 22.22 Sell
50-day SMA: 23.4 Sell
200-day SMA: 26.95 Sell
8-day EMA: 21.16 Sell
20-day EMA: 22 Sell
50-day EMA: 23.31 Sell
200-day EMA: 26.81 Sell

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 104.73 Buy
20-day SMA: 108.33 Sell
50-day SMA: 116.79 Sell
200-day SMA: 127.98 Sell
8-day EMA: 104.59 Buy
20-day EMA: 108.12 Sell
50-day EMA: 115.21 Sell
200-day EMA: 120.83 Sell

Genmab AS Earnings Growth & GMAB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.16 per share, and an increase next year of $0.28 per share.

Novo Nordisk AS Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and an increase next year of $0.74 per share.

Genmab AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):